Jazz Pharmaceuticals: Gala proposes $225K share sale

The notice identifies the proposed shares as restricted stock acquired from the issuer on June 30, 2026, and lists two earlier sales.

Available on EDGAR 11/03/2026 - 04:23 PM EST Accepted by SEC EDGAR 11/03/2026 - 04:23 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Jazz Pharmaceuticals plc (JAZZ) is named in a Rule 144 notice concerning officer and director Renee D. Gala’s proposed sale of 1,000 common shares, with an aggregate market value of $225,370, on November 3, 2026, through Morgan Stanley Smith Barney LLC on Nasdaq. The notice identifies the shares as restricted stock acquired from the issuer on June 30, 2026. It also reports sales of 2,000 shares on October 6, 2026, for $472,800 and 2,000 shares on September 8, 2026, for $486,060.

Key Figures

Proposed sale: 1,000 common shares Aggregate market value: $225,370 Shares outstanding: 64,189,052 shares +4 more

7 metrics

Proposed sale 1,000 common shares Proposed for November 3, 2026

Aggregate market value $225,370 Proposed sale

Shares outstanding 64,189,052 shares Reported in the securities information

Prior sale 2,000 common shares October 6, 2026

Prior sale aggregate market value $472,800 Sale on October 6, 2026

Prior sale 2,000 common shares September 8, 2026

Prior sale aggregate market value $486,060 Sale on September 8, 2026

Key Terms

Rule 144, Restricted Stock, Aggregate market value

3 terms

Rule 144 regulatory

"definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock financial

"Common | 06/30/2026 | Restricted Stock | ISSUER"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Aggregate market value financial

"Securities Information"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many JAZZ shares does Renee D. Gala propose to sell, and for how much?

Renee D. Gala’s notice covers 1,000 common shares with an aggregate market value of $225,370, for a proposed sale on November 3, 2026, through Morgan Stanley Smith Barney LLC on Nasdaq.

What recent JAZZ share sales did Renee D. Gala report?

The notice reports that Renee D. Gala sold 2,000 common shares on October 6, 2026, for $472,800, and 2,000 common shares on September 8, 2026, for $486,060. These are listed as sales during the past three months.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001607737
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
SEC File Number	001-33500
Address of Issuer	Fifth Floor, Waterloo Exchange Waterloo Road Dublin 4 IRELAND D04 E5W7
Phone	011-353-1-634-7800
Name of Person for Whose Account the Securities are To Be Sold	RENEE D GALA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1000	225370.00	64189052	11/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/30/2026	Restricted Stock	ISSUER			1000	06/30/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
RENEE D GALA Fifth Floor, Waterloo Exchange Waterloo Road Dublin 4 L2 D04 E5W7	Common	10/06/2026	2000	472800.00
RENEE D GALA Fifth Floor, Waterloo Exchange Waterloo Road Dublin 4 L2 D04 E5W7	Common	09/08/2026	2000	486060.00

144: Remarks and Signature

Remarks
Date of Notice	11/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Renee Gala
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)